AVDL vs EIX · rev $169.1M vs P/E 7.3, rev $17.60B
Avadel Pharmaceuticals PLC (AVDL) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
AVDL currently screens at market cap $968.5M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the AVDL and EIX stock pages for the full models.
Not investment advice.